Zobrazeno 1 - 10
of 61
pro vyhledávání: '"C. Girouard"'
Autor:
Baoshan Gao, Fabrice Porcheray, Carolina Moore, Susan L. Saidman, Emmanuel Zorn, Chunshu Rong, Waichi Wong, Timothy C. Girouard, Yaowen Fu
Publikováno v:
Transplantation. 100:217-226
Background Assessing the serum reactivity to HLA is essential for the evaluation of transplant candidates and the follow-up of allograft recipients. In this study, we look for evidence at the clonal level that polyreactive antibodies cross-reactive t
Publikováno v:
Research in socialadministrative pharmacy : RSAP. 14(10)
Background The evidence-based heart failure (HF) drug treatment is made of a β-blocker and an angiotensin-converting enzyme inhibitor or an angiotensin II receptor blocker, or hydralazine + isosorbide dinitrate. Little is known about sex-based diffe
Autor:
Jeremy A. Peña, Robert S. Makar, Timothy C. Girouard, Erin Meister, Walter H. Dzik, Susan L. Saidman
Publikováno v:
American Journal of Hematology. 89:E133-E137
Alloimmune platelet refractoriness (alloPR) among actively bleeding surgical patients with thrombocytopenia represents a life-threatening problem. Here we present three cases in which surgical bleeding was complicated by life-threatening thrombocytop
Publikováno v:
Patient preference and adherence
Catherine Girouard,1–3 Jean-Pierre Grégoire,1–3 Paul Poirier,2,4 Jocelyne Moisan1–3 1Chair on Adherence to Treatments, Université Laval, 2Faculty of Pharmacy, Université Laval, 3Population Health and Optimal Health Practices Research Unit, C
Publikováno v:
Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique. 23(1)
Little is known about exposure to heart failure (HF) treatment among seniors with ischemic heart disease.In a population of seniors, we: 1) estimated the association between age and exposure to HF drug therapy at 6, 12, 36 and 60 month intervals afte
Autor:
Waichi Wong, Christian LeGuern, Jack Ferdman, Timothy C. Girouard, Tatsuo Kawai, Susan L. Saidman, Priscilla Nobecourt, James W. Fraser, Julie DeVito, Robert B. Colvin, Ynes Helou, Ian Dargon, Sharon Germana, Fabrice Porcheray, Emmanuel Zorn
Publikováno v:
American Journal of Transplantation
Antibody rejection is often accompanied by nondonor HLA specific antibodies (NDSA) and self-reactive antibodies that develop alongside donor-specific antibodies (DSA). To determine the source of these antibodies, we immortalized 107 B-cell clones fro
Publikováno v:
Value in Health. 18(7)
Autor:
Julie DeVito, Beow Y. Yeap, Lijuan Xue, Ian Dargon, Timothy C. Girouard, Waichi Wong, Fabrice Porcheray, Emmanuel Zorn, Rosemary Paine, Susan L. Saidman, Robert B. Colvin
Publikováno v:
Transplantation. 89:1239-1246
Chronic humoral rejection (CHR) is currently recognized as one of the most serious complications after kidney transplantation. The reason why some transplant recipients develop CHR and others do not is still unknown. CHR is primarily characterized by
Publikováno v:
Scopus-Elsevier
ATP bioluminescence was evaluated as a method for assessing the level of microbial contamination in sap and predicting maple syrup characteristics. This approach provided results that were strongly correlated with the standard plate count and took le
Autor:
V. Drouin, M. Ruel, J. Gilbert, H. Vaillancourt, C. McGinn, M. Poiré, C. Girouard, C. Kroon, L. Bernier, Don Melady, Audrey Dupuis, Patrick Archambault, J. Rivard, A. Savard
Publikováno v:
CJEM. 19:S80
Introduction: Decreasing readmission rates and return emergency department (ED) visits represent a major challenge for health organizations. Seniors are especially vulnerable to discharge adverse events which can result in unplanned readmissions and